Arranta Bio Selected As 2020 Florida Companies to Watch Finalist
September 01, 2020
.png)
(Gainesville, FL) Arranta Bio was among the first round of the 2020 Florida Companies to Watch finalists recently announced by GrowFL. The awards event - now in its tenth year - honors impressive second-stage companies from throughout the state for developing valuable products and services, creating quality jobs, enriching communities, and broadening new industries throughout Florida.
Arranta provides CDMO services to support industry pioneers in bringing life-changing microbiome-based therapies to patients in need. The company’s Center of Excellence for process and analytical development and early clinical supply for microbiome clients was established in 2019 following the acquisition of Captozyme, a veteran CDMO and graduate of the UF Innovate Sid Martin Biotech program. In addition to the Center of Excellence in Gainesville, Arranta Bio’s operation includes a late-stage clinical supply and commercial facility in Watertown, MA, due to open by the end of 2020.
“Arranta Bio is honored to be selected as a finalist in the GrowFL companies to watch award. For over 10 years our team, under the leadership of our CSO, Dr. Aaron Cowley, built the expertise to help companies in the emerging field of the human microbiome, and we are now expanding our team and facilities in Gainesville, Florida, to increase the impact that we will make on delivering therapies to patients,” Mark Bamforth, CEO of Arranta Bio, said.
The finalists were selected from more than 400 nominations and are now in the running to be named a 2020 GrowFL Florida Companies to Watch Honoree. If selected as an honoree, these exemplary second-stage companies will join the 450 honorees that have been recognized since 2011.
“We applaud these first-round finalists who have proved themselves to be stand out companies in the state. They have and continue to demonstrate the resiliency and tenacity that comes along with being an entrepreneur. We know this year hasn’t been easy, so we’re excited to recognize our state's admirable business owners and their teams. I have a feeling they’re just getting started,” said Dr. Tom O’Neal, GrowFL Founder.
Together, the 2020 GrowFL Florida Companies to Watch Finalists represent nearly 3,000 jobs and generate $670 million in revenue. These companies, all of which are “worth watching,” anticipate a growth of 13 percent in revenue and 23 percent in employment by the end of 2020. The 2020 GrowFL Florida Companies to Watch awards celebration is brought to you by Nperspective CFO & Strategic Services, in association with the Edward Lowe Foundation.
The Finalists represent a unique group of scalable, high-growth enterprises that are already located within Florida. These high growth enterprises are an important segment of our economy and their numbers have been steadily increasing. According to the Kauffman Foundation, “entrepreneurship is not a monolithic phenomenon, and it includes many moving parts. Creating new businesses is a different economic activity from running small businesses, which in turn is different from growing businesses.” GrowFL Florida Companies to Watch recognizes the different approaches needed to successfully grow and scale a business and celebrates those that are working to achieve this goal.
Companies to Watch was developed by the Edward Lowe Foundation as a unique way to recognize and honor second-stage companies that demonstrate high performance in the marketplace with innovative strategies and processes. In addition to evaluating past growth and projected success, applicant companies are judged according to their special strengths and impact in their markets, communities, and within the state – thus deeming them “worth watching.”
The 2020 honorees will be recognized on November 12, 2020 at 6 pm during a live broadcast from Orlando, Florida. For more information visit https://www.growfl.com/flctw20/about-flctw/.
###
About Arranta Bio
Founded in 2019, Arranta Bio is a contract development and manufacturing organization (CDMO) specifically established to focus on serving companies seeking to develop and commercialize therapies targeting the human microbiome. In November 2019, Arranta Bio acquired Captozyme™ – the leader in process development and clinical contract manufacturing for microbiome pioneers – whose experienced team has worked with and developed processes for over 135 different species spanning 85 different genera of live biotherapeutics since 2009. Headed by a management team and technical experts with a proven track record in both process development and contract manufacturing through fermentation to lyophilization and encapsulation of live biopharmaceuticals, Arranta Bio offers the knowledge and resources necessary to help clients develop and manufacture promising new microbiome therapies to meet the needs of patients. Additional information about Arranta Bio is available at www.arrantabio.com. Enquiries can be sent to info@arrantabio.com.
About?GrowFL:??
GrowFL?is dedicated to support and accelerate the growth of second-stage companies throughout Florida, by providing their leaders focused, efficient, and timely access to resources they deem important, such as connections with other second-stage company leaders, and to professional organizations whose expertise, experience, and products lead to the second-stage company’s continued growth and prosperity resulting in diversification and growth of Florida’s economy.? Second-stage growth companies have at least 10 employees and a $1 million in revenue and possess an intent and desire to grow beyond?second stage.? Website:?http://www.growfl.com?
About?the Edward Lowe Foundation:??
Established in 1985, the Edward Lowe Foundation is a national, nonprofit organization that supports entrepreneurship through research, recognition and educational programs, which are delivered through entrepreneur support organizations (ESOs).? The foundation focuses on second-stage companies — those that have moved beyond the startup phase and seek significant, steady growth. In addition, the foundation has a second mission of land stewardship and is committed to preserving the natural resources and historically significant structures at Big Rock Valley, its 2,000-acre home in southwest Michigan.?Website:?https://edwardlowe.org/??
Arranta provides CDMO services to support industry pioneers in bringing life-changing microbiome-based therapies to patients in need. The company’s Center of Excellence for process and analytical development and early clinical supply for microbiome clients was established in 2019 following the acquisition of Captozyme, a veteran CDMO and graduate of the UF Innovate Sid Martin Biotech program. In addition to the Center of Excellence in Gainesville, Arranta Bio’s operation includes a late-stage clinical supply and commercial facility in Watertown, MA, due to open by the end of 2020.
“Arranta Bio is honored to be selected as a finalist in the GrowFL companies to watch award. For over 10 years our team, under the leadership of our CSO, Dr. Aaron Cowley, built the expertise to help companies in the emerging field of the human microbiome, and we are now expanding our team and facilities in Gainesville, Florida, to increase the impact that we will make on delivering therapies to patients,” Mark Bamforth, CEO of Arranta Bio, said.
The finalists were selected from more than 400 nominations and are now in the running to be named a 2020 GrowFL Florida Companies to Watch Honoree. If selected as an honoree, these exemplary second-stage companies will join the 450 honorees that have been recognized since 2011.
“We applaud these first-round finalists who have proved themselves to be stand out companies in the state. They have and continue to demonstrate the resiliency and tenacity that comes along with being an entrepreneur. We know this year hasn’t been easy, so we’re excited to recognize our state's admirable business owners and their teams. I have a feeling they’re just getting started,” said Dr. Tom O’Neal, GrowFL Founder.
Together, the 2020 GrowFL Florida Companies to Watch Finalists represent nearly 3,000 jobs and generate $670 million in revenue. These companies, all of which are “worth watching,” anticipate a growth of 13 percent in revenue and 23 percent in employment by the end of 2020. The 2020 GrowFL Florida Companies to Watch awards celebration is brought to you by Nperspective CFO & Strategic Services, in association with the Edward Lowe Foundation.
The Finalists represent a unique group of scalable, high-growth enterprises that are already located within Florida. These high growth enterprises are an important segment of our economy and their numbers have been steadily increasing. According to the Kauffman Foundation, “entrepreneurship is not a monolithic phenomenon, and it includes many moving parts. Creating new businesses is a different economic activity from running small businesses, which in turn is different from growing businesses.” GrowFL Florida Companies to Watch recognizes the different approaches needed to successfully grow and scale a business and celebrates those that are working to achieve this goal.
Companies to Watch was developed by the Edward Lowe Foundation as a unique way to recognize and honor second-stage companies that demonstrate high performance in the marketplace with innovative strategies and processes. In addition to evaluating past growth and projected success, applicant companies are judged according to their special strengths and impact in their markets, communities, and within the state – thus deeming them “worth watching.”
The 2020 honorees will be recognized on November 12, 2020 at 6 pm during a live broadcast from Orlando, Florida. For more information visit https://www.growfl.com/flctw20/about-flctw/.
###
About Arranta Bio
Founded in 2019, Arranta Bio is a contract development and manufacturing organization (CDMO) specifically established to focus on serving companies seeking to develop and commercialize therapies targeting the human microbiome. In November 2019, Arranta Bio acquired Captozyme™ – the leader in process development and clinical contract manufacturing for microbiome pioneers – whose experienced team has worked with and developed processes for over 135 different species spanning 85 different genera of live biotherapeutics since 2009. Headed by a management team and technical experts with a proven track record in both process development and contract manufacturing through fermentation to lyophilization and encapsulation of live biopharmaceuticals, Arranta Bio offers the knowledge and resources necessary to help clients develop and manufacture promising new microbiome therapies to meet the needs of patients. Additional information about Arranta Bio is available at www.arrantabio.com. Enquiries can be sent to info@arrantabio.com.
About?GrowFL:??
GrowFL?is dedicated to support and accelerate the growth of second-stage companies throughout Florida, by providing their leaders focused, efficient, and timely access to resources they deem important, such as connections with other second-stage company leaders, and to professional organizations whose expertise, experience, and products lead to the second-stage company’s continued growth and prosperity resulting in diversification and growth of Florida’s economy.? Second-stage growth companies have at least 10 employees and a $1 million in revenue and possess an intent and desire to grow beyond?second stage.? Website:?http://www.growfl.com?
About?the Edward Lowe Foundation:??
Established in 1985, the Edward Lowe Foundation is a national, nonprofit organization that supports entrepreneurship through research, recognition and educational programs, which are delivered through entrepreneur support organizations (ESOs).? The foundation focuses on second-stage companies — those that have moved beyond the startup phase and seek significant, steady growth. In addition, the foundation has a second mission of land stewardship and is committed to preserving the natural resources and historically significant structures at Big Rock Valley, its 2,000-acre home in southwest Michigan.?Website:?https://edwardlowe.org/??
Contact:
Amanda Austin, Marketing Manager
Amanda.austin@arrantabio.com, (352) 363-2912 ext. 950